Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

IVAX Think Big with Zaponex Launch

Ivax Pharmaceuticals
Posted on: 18 Jan 05
29 th November 2004:
IVAX Pharmaceuticals UK has today announced the launch of their alternative brand of clozapine, Zaponex Tablets (prescribing information), for treatment resistant schizophrenia and severe thought disturbances in patients with Parkinson’s disease.
IVAX’ Zaponex Tablets are available in highly acclaimed patient pack presentations of 84 tablets of 25mg for £36.97 and 100mg for £147.84. 1

Excellent value delivers big budget savings with NEW Zaponex and patients can depend on consistent product quality from IVAX, a leading supplier of generic medicines to the NHS with over 300 product lines.

A tried and tested patient monitoring system that is both flexible and easy to use has also been developed for complete commitment to care. 24 hours a day, 7 days a week haematological results and full back-up support is available by a team of experts

Called ZTAS (Zaponex Treatment Access System), those familiar with other patient monitoring systems will be well acquainted with the protocol and will not have to implement new processes.

To make the simple switch to NEW Zaponex you can visit or call 0207 3655842, e-mail or call 08705 02 03 04.

References: 1.NHS List Price, November 2004.

More Information

Editor's Details

Claire Phillpot
01628 668348

Last updated on: 27/08/2010

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.